UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline

The international journal of tuberculosis and lung disease, 2022-06, Vol.26 (6), p.571-573

2022

Volltextzugriff (PDF)

Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis

Antimicrobial Agents and Chemotherapy, 2009-09, Vol.53 (9), p.3782-3792

2009

Volltextzugriff (PDF)

Pharmacokinetics, Serum Inhibitory and Bactericidal Activity, and Safety of Telavancin in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 2005-01, Vol.49 (1), p.195-201

2005

Volltextzugriff (PDF)

Homologs of the Shigella IpaB and IpaC invasins are required for Salmonella typhimurium entry into cultured epithelial cells

Journal of Bacteriology, 1995-07, Vol.177 (14), p.3965-3971

1995

Volltextzugriff (PDF)

Identification of two targets of the type III protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA proteins

Journal of Bacteriology, 1995-12, Vol.177 (24), p.7078-7085

1995

Volltextzugriff (PDF)

GC-MS Analysis and Antimicrobial Activities of Alkaloid Extracts of Tinospora Cordifolia

International journal of pharma and bio sciences, 2021-10, Vol.12 (4), p.13-20

2021

Volltextzugriff (PDF)

A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid

Journal of clinical microbiology, 2016-12, Vol.54 (12), p.2963-2968

2016

Volltextzugriff (PDF)

A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing

Journal of clinical microbiology, 2016-12, Vol.54 (12), p.2956-2962

2016

Volltextzugriff (PDF)

Telavancin, a Multifunctional Lipoglycopeptide, Disrupts both Cell Wall Synthesis and Cell Membrane Integrity in Methicillin-Resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2005-03, Vol.49 (3), p.1127-1134

2005

Volltextzugriff (PDF)

Safety and Efficacy of Intravenous Doripenem for the Treatment of Complicated Urinary Tract Infections and Pyelonephritis

Journal of chemotherapy (Florence), 2010-12, Vol.22 (6), p.384-391

2010

Volltextzugriff (PDF)

Pharmacodynamics of Telavancin (TD-6424), a Novel Bactericidal Agent, against Gram-Positive Bacteria

Antimicrobial Agents and Chemotherapy, 2004-08, Vol.48 (8), p.3043-3050

2004

Volltextzugriff (PDF)

Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains

Antimicrobial Agents and Chemotherapy, 2005-08, Vol.49 (8), p.3501-3512

2005

Volltextzugriff (PDF)

Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria

Journal of antimicrobial chemotherapy, 2004-05, Vol.53 (5), p.797-803

2004

Volltextzugriff (PDF)

P833 Intravenous therapy with doripenem versus levofioxacin with an option for oral step-down therapy in the treatment of complicated urinary tract infections and pyelonephritis

International journal of antimicrobial agents, 2007, Vol.29, p.S212-S212

2007

Volltextzugriff (PDF)

P834 Treatment of complicated intra-abdominal infections: doripenem versus meropenem

International journal of antimicrobial agents, 2007, Vol.29, p.S212-S212

2007

Volltextzugriff (PDF)

Efficacy of Telavancin (TD-6424), a Rapidly Bactericidal Lipoglycopeptide with Multiple Mechanisms of Action, in a Murine Model of Pneumonia Induced by Methicillin-Resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2005-10, Vol.49 (10), p.4344-4346

2005

Volltextzugriff (PDF)

In Vitro Activity of TD-6424 against Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2003-11, Vol.47 (11), p.3602-3604

2003

Volltextzugriff (PDF)

In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis

Médecine et maladies infectieuses, 2016-06, Vol.46 (4), p.220-225

2016

Volltextzugriff (PDF)

In Vitro Activity of Doripenem (S-4661) against Multidrug-Resistant Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis

Antimicrobial Agents and Chemotherapy, 2005-06, Vol.49 (6), p.2510-2511

2005

Volltextzugriff (PDF)

Salmonella spp. are cytotoxic for cultured macrophages

Molecular microbiology, 1996-09, Vol.21 (5), p.1101-1115

1996

Volltextzugriff (PDF)

Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests

Journal of antimicrobial chemotherapy, 2005-12, Vol.56 (6), p.1047-1052

2005

Volltextzugriff (PDF)

ymoA, a Yersinia enterocolitica chromosomal gene modulating the expression of virulence functions

Molecular microbiology, 1991-05, Vol.5 (5), p.1023-1034

1991

Volltextzugriff (PDF)

A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium

Molecular microbiology, 1996-08, Vol.21 (3), p.633-641

1996

Volltextzugriff (PDF)

The Salmonella typhimurium invasion genes invF and invG encode homologues of the AraC and PulD family of proteins

Molecular microbiology, 1994-08, Vol.13 (4), p.555-568

1994

Volltextzugriff (PDF)

A wide-host-range suicide vector for improving reverse genetics in Gram-negative bacteria: inactivation of the blaA gene of Yersinia enterocolitica

Gene, 1991-12, Vol.109 (1), p.137-141

1991

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline

Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis

Pharmacokinetics, Serum Inhibitory and Bactericidal Activity, and Safety of Telavancin in Healthy Subjects

Homologs of the Shigella IpaB and IpaC invasins are required for Salmonella typhimurium entry into cultured epithelial cells

Identification of two targets of the type III protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA proteins

GC-MS Analysis and Antimicrobial Activities of Alkaloid Extracts of Tinospora Cordifolia

A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid

A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing

Telavancin, a Multifunctional Lipoglycopeptide, Disrupts both Cell Wall Synthesis and Cell Membrane Integrity in Methicillin-Resistant Staphylococcus aureus

Safety and Efficacy of Intravenous Doripenem for the Treatment of Complicated Urinary Tract Infections and Pyelonephritis

Pharmacodynamics of Telavancin (TD-6424), a Novel Bactericidal Agent, against Gram-Positive Bacteria

Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains

Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria

P833 Intravenous therapy with doripenem versus levofioxacin with an option for oral step-down therapy in the treatment of complicated urinary tract infections and pyelonephritis

P834 Treatment of complicated intra-abdominal infections: doripenem versus meropenem

Efficacy of Telavancin (TD-6424), a Rapidly Bactericidal Lipoglycopeptide with Multiple Mechanisms of Action, in a Murine Model of Pneumonia Induced by Methicillin-Resistant Staphylococcus aureus

In Vitro Activity of TD-6424 against Staphylococcus aureus

In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis

In Vitro Activity of Doripenem (S-4661) against Multidrug-Resistant Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis

Salmonella spp. are cytotoxic for cultured macrophages

Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests

ymoA, a Yersinia enterocolitica chromosomal gene modulating the expression of virulence functions

A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium

The Salmonella typhimurium invasion genes invF and invG encode homologues of the AraC and PulD family of proteins

A wide-host-range suicide vector for improving reverse genetics in Gram-negative bacteria: inactivation of the blaA gene of Yersinia enterocolitica

Suchergebnisse filtern